Clinical Trials Directory

Trials / Terminated

TerminatedNCT02716896

Radical Cystectomy Compared With Chemoradiation for Muscle Invasive Bladder Cancer

Radical Cystectomy Compared With Chemoradiation for Muscle Invasive Bladder Cancer: A Pilot, Randomized-Controlled Non-Inferiority Trial

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
2 (actual)
Sponsor
The University of Texas Health Science Center at San Antonio · Academic / Other
Sex
All
Age
18 Years – 89 Years
Healthy volunteers
Not accepted

Summary

Currently the standard treatment of muscle invasive bladder cancer is the complete removal of bladder and adjacent organs, such as prostate or ovaries. Radical cystectomy is fraught with complications and risk of death. The researchers hope to learn if chemoradiation (i.e. using chemotherapy and radiation), also an acceptable treatment for muscle invasive bladder cancer, can be used a good alternative therapy option.

Detailed description

Currently the standard treatment of muscle invasive bladder cancer is the complete removal of bladder and adjacent organs, such as prostate or ovaries. Such procedure is highly invasive and undesirable for some patients. The researchers hope to learn if chemoradiation, using chemotherapy and radiation, can be a good alternative therapy option. Chemoradiation therapy is also currently considered an acceptable clinical approach but is typically used for treatment in patients with muscle invasive bladder cancer who have other medical issues that might cause complications during or after undergoing surgery. Disease free survival at 5 years is better for those who had their bladder removed, but overall survival rates for chemoradiation therapy patients are comparable between the two approaches.

Conditions

Interventions

TypeNameDescription
RADIATIONRadiation and chemoradiationRadiation and chemotherapy will be administered concurrently to those who are randomized to this group.
PROCEDURERadical cystectomyRadical cystectomy will be performed on those who are randomized to this group.

Timeline

Start date
2016-05-01
Primary completion
2018-03-26
Completion
2018-03-26
First posted
2016-03-23
Last updated
2019-11-25
Results posted
2019-11-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02716896. Inclusion in this directory is not an endorsement.